Hepatocyte membrane stabilization via cytoprotective effect of ursodeoxycholic acid

The phrase "Hepatocyte membrane stabilization/protection via cytoprotective effect of UDCA" does not refer to a single molecular target such as a receptor, enzyme, or transporter. Instead, it describes the pharmacological action exerted by the drug ursodeoxycholic acid (UDCA) on hepatocytes. UDCA is a secondary hydrophilic bile acid widely used for treating various liver diseases characterized by impaired bile flow and accumulation of toxic hydrophobic bile acids. Its main actions include stabilizing hepatocyte plasma membranes against damage from these toxic compounds; inhibiting apoptosis through prevention of mitochondrial pore formation; reducing oxidative stress; modulating immune responses within the liver; enhancing secretion and flow of less-toxic bile acids; and altering expression or function of transporters involved in biliary excretion. These combined effects result in broad cytoprotection for hepatic cells under pathological conditions like cholestasis or chronic inflammation. Because this entry refers to an overall protective mechanism rather than an individual protein or gene product that can be directly targeted by drugs other than UDCA itself, it should not be considered a canonical therapeutic target. Summary: This is not a discrete molecular target but rather describes the multifaceted protective actions mediated by ursodeoxycholic acid on hepatocytes. The correct canonical form would be "Ursodeoxycholic acid" as the agent responsible for these effects—not "hepatocyte membrane stabilization/protection," which is an outcome/process rather than a molecule/receptor.

Other names

Hepatocyte membrane protection by UDCACytoprotective effect of ursodeoxycholic acidUDCA-mediated hepatoprotection

Displacement and dilution of toxic hydrophobic bile acids with hydrophilic UDCA, reducing their cytotoxicity; Stabilization of plasma and mitochondrial membranes in hepatocytes, preventing cell death; Inhibition of mitochondrial permeability transition pore opening induced by toxic bile salts; Stimulation of anti-apoptotic pathways and reduction in reactive oxygen species production.